ReviewESMO open2023
Design, power, and alpha levels in randomized phase II oncology trials.
A Haslam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it
ReviewESMO open2023
A Haslam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.